Aditxt, Inc. (ADTX)
NASDAQ: ADTX · Real-Time Price · USD
0.1069
-0.0103 (-8.79%)
Jun 1, 2026, 1:14 PM EDT - Market open
Aditxt Employees
Aditxt had 26 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
26
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$551
Profits / Employee
-$2,051,495
Market Cap
2.05K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 26 | 0 | - |
| Dec 31, 2024 | 26 | -21 | -44.68% |
| Dec 31, 2023 | 47 | -14 | -22.95% |
| Dec 31, 2022 | 61 | 3 | 5.17% |
| Dec 31, 2021 | 58 | 15 | 34.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Jaguar Health | 47 |
| Scinai Immunotherapeutics | 45 |
| Silexion Therapeutics | 14 |
| Biodexa Pharmaceuticals | 11 |
| Ensysce Biosciences | 10 |
| Artelo Biosciences | 7 |
| Onconetix | 2 |
ADTX News
- 5 hours ago - Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders - Business Wire
- 18 days ago - Aditxt announces 1-for-27 reverse stock split - TheFly
- 18 days ago - Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026 - Business Wire
- 6 weeks ago - Aditxt announces publication featuring Ignite Proteomics subsidiary - TheFly
- 6 weeks ago - Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics' RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients - Business Wire
- 7 weeks ago - Aditxt files to sell 148.28M shares of common stock for holders - TheFly
- 2 months ago - Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer - Business Wire
- 2 months ago - Aditxt acquires Ignite Proteomics in $36M transaction - TheFly